Blueprint Medicines - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $89,358.65 -2.93%
Ethereum $2,977.96 -6.07%
BNB $879.45 -5.07%
Optimism $0.31 -1.90%
Arbitrum $0.19 -3.51%
Solana $127.66 -4.22%
Polygon $0.22 +2.77%
Cosmos $2.37 -6.09%
Avalanche $12.26 -3.47%

Bitcoin $89,358.65 -2.93%
Ethereum $2,977.96 -6.07%
BNB $879.45 -5.07%
Optimism $0.31 -1.90%
Arbitrum $0.19 -3.51%
Solana $127.66 -4.22%
Polygon $0.22 +2.77%
Cosmos $2.37 -6.09%
Avalanche $12.26 -3.47%

Blueprint Medicines

company

Investors

Number of Lead Investors

Number of Investors

4

15

Blueprint Medicines is funded by 15 investors. Partner Fund Management and Eight Roads Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Partner Fund Management	Yes	Series C
Eight Roads Ventures	Yes	Series Unknown
Casdin Capital	-	Series C
Cowen Group	-	Series C
Fidelity Biosciences	-	Series C
Nextech Invest	-	Series C
Perceptive Advisors	-	Series C
RA Capital Management	-	Series C
Redmile Group	-	Series C
Sabby Capital	-	Series C
Tavistock Life Sciences	-	Series C
Third Rock Ventures	-	Series C
Wellington Management	-	Series C
Biotechnology Value Fund	-	Series B
F-Prime Capital	-	Series B